Boston Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Boston Technology Review.

Press releases published on July 15, 2026

Jul. 15, 2026

Discover, Make, Connect: FAB26 Boston Opens Its Doors to the World July 27

Indeterminate EIN Presswire

Jul. 15, 2026

Modo Labs® Announces Workday® Student Integration for Unified Digital Campus Experiences

Indeterminate EIN Presswire

Jul. 15, 2026

Accelevents Names Laura Hall as Vice President of Marketing

Indeterminate EIN Presswire

Jul. 15, 2026

OASIS Approves Two Public-Key Cryptography Standards to Advance Post-Quantum Security and Interoperability

Indeterminate EIN Presswire

Jul. 15, 2026

CPR Therapeutics, Inc. Selected for Inaugural Cohort of the Auxilium–MBI Accelerator

Indeterminate EIN Presswire

Jul. 15, 2026

Creatio Introduces 10x Release to Power the Unlimited Enterprise

Indeterminate EIN Presswire

Jul. 15, 2026

Cloudastructure Schedules Q1 2026 Earnings Call 

Indeterminate GlobeNewswire

Jul. 15, 2026

Japan’s Enterprises and Startups Build Industry-Specialized AI With NVIDIA Nemotron Open Models

Indeterminate GlobeNewswire

Jul. 15, 2026

Xanadu to Report Second Quarter 2026 Financial Results on August 5th, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Synaptics to Release Fourth Quarter and Full Year Fiscal 2026 Results on August 6, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Neutrolis Announces New England Journal of Medicine Publication Demonstrating First Clinical Evidence for NET-Degrading Therapy in Severe, Treatment-Refractory Systemic Lupus Erythematosus (SLE) Caused by DNASE1L3 Deficiency

Indeterminate GlobeNewswire

Jul. 15, 2026

Cytek® Biosciences Opens New Innovation Center in Bellevue to Advance R&D and Customer Engagement

Indeterminate GlobeNewswire

Jul. 15, 2026

Landmark ECOG-ACRIN ENDURANCE Study Co-Authored by International Myeloma Foundation Leaders Provides Evidence for Optimal Duration of Maintenance Therapy

Indeterminate GlobeNewswire

Jul. 15, 2026

Rakovina Therapeutics Announces $1.5 Million Private Placement

Indeterminate GlobeNewswire

Jul. 15, 2026

First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer

Indeterminate GlobeNewswire

Jul. 15, 2026

Certara to Report Second Quarter 2026 Financial Results on August 4th, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

EverQuote to Announce Second Quarter 2026 Financial Results on August 3, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

PacBio to Report Second Quarter 2026 Financial Results on August 5, 2026

Indeterminate GlobeNewswire

Jul. 15, 2026

Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire

Jul. 15, 2026

Surrozen to Present at Upcoming Healthcare Investor Conference

Indeterminate GlobeNewswire